W
Won Il Jang
Researcher at New Generation University College
Publications - 59
Citations - 1180
Won Il Jang is an academic researcher from New Generation University College. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 16, co-authored 38 publications receiving 844 citations. Previous affiliations of Won Il Jang include Seoul National University Bundang Hospital.
Papers
More filters
Journal ArticleDOI
2018 Korean Liver Cancer Association-National Cancer Center Korea practice guidelines for the management of hepatocellular carcinoma
Joong-Won Park,June Sung Lee,Kyung-Suk Suh,Jin Wook Chung,Jinsil Seong,Do Young Kim,Ji-Hoon Kim,Hyeong Jun Kim,Hwi Young Kim,Soo-Young Park,Joo Hyeon Shim,Jeong Hoon Lee,Young-Suk Lim,Ho Yeong Lim,Jeong Won Jang,Jae Young Jang,Dae Won Jeon,Yang Seok Ko,Kyung Sik Kim,Dong-Sik Kim,Seong Hoon Kim,Jong Man Kim,Yeong Cheol Yun,Dong Hwan Jeong,Jai Young Cho,Young Hwan Koh,Kyeong Min Kim,So Yeon Kim,Young Hwan Kim,In Joon Lee,Jeong Min Lee,Hyeon Cheol Lim,Sung Ki Cho,Ho Jong Cheon,Jun Il Choi,Chul Seung Kay,Mi Sook Kim,Tae Hyun Kim,Hee Chul Park,Sun Hyeon Bae,Sang Min Yoon,Won Sup Yoon,Won Il Jang +42 more
TL;DR: New recommendations that integrate the most up-to-date research findings and expert opinions are developed that will provide useful and constructive advice for the clinical management of patients with HCC.
Journal ArticleDOI
2014 Korean Liver Cancer Study Group-National Cancer Center Korea practice guideline for the management of hepatocellular carcinoma
Joong-Won Park,June Sung Lee,Kyung-Suk Suh,Jin Wook Chung,Jinsil Seong,Do Young Kim,Ji-Hoon Kim,Hyeong Jun Kim,Hwi Young Kim,Soo-Young Park,Joo Hyeon Shim,Jeong Hoon Lee,Young-Suk Lim,Ho Yeong Lim,Jeong Won Jang,Jae Young Jang,Dae Won Jeon,Yang Seok Ko,Kyung Sik Kim,Dong-Sik Kim,Seong Hoon Kim,Jong Man Kim,Yeong Cheol Yun,Dong Hwan Jeong,Jai Young Cho,Young Hwan Koh,Kyeong Min Kim,So Yeon Kim,Young Hwan Kim,In Joon Lee,Jeong Min Lee,Hyeon Cheol Lim,Sung Ki Cho,Ho Jong Cheon,Jun Il Choi,Chul Seung Kay,Mi Sook Kim,Tae Hyun Kim,Hee Chul Park,Sun Hyeon Bae,Sang Min Yoon,Won Sup Yoon,Won Il Jang,Korean Liver Canc Assoc Klca,Natl Canc Ctr Ncc +44 more
TL;DR: This guideline provides recommendations for the initial treatment of patients with newly diagnosed HCC and is developed on the basis of recent evidence and expert opinions.
Journal ArticleDOI
A phase 2 multicenter study of stereotactic body radiotherapy for hepatocellular carcinoma: Safety and efficacy.
Won Il Jang,Sun Hyun Bae,Mi-Sook Kim,Chul Han,Su Cheol Park,Sang Bum Kim,Eung Ho Cho,Chul Won Choi,Kyung-Su Kim,Sangyoun Hwang,Jin Ho Kim,A. Ram Chang,Younghee Park,Eun Seog Kim,Woo Chul Kim,Sunmi Jo,Hae Jin Park +16 more
TL;DR: The authors evaluated the safety and efficacy of SBRT for patients with HCC in a hepatitis B virus‐endemic area and found the treatment-related toxicity varies and has not been determined.
Journal Article
Stereotactic Body Radiotherapy for Recurrent or Oligometastatic Uterine Cervix Cancer: A Cooperative Study of the Korean Radiation Oncology Group (KROG 14-11).
TL;DR: SBRT for recurrent or oligometastatic cervical cancer resulted in excellent local control, especially with a long disease-free interval and high BED treatment, with acceptable toxicities, therefore, SBRT can be considered a therapeutic option for these patients.
Journal ArticleDOI
Outcomes of stereotactic body radiotherapy for unresectable primary or recurrent cholangiocarcinoma.
Da Hoon Jung,Mi-Sook Kim,Chul Koo Cho,Hyung Jun Yoo,Won Il Jang,Young Seok Seo,Eun Kyung Paik,Kum Bae Kim,Chul Han,Sang Bum Kim +9 more
TL;DR: SBRT can be considered as an effective local modality for unresectable primary or recurrent cholangiocarcinoma and showed statistically significant higher overall survival rate in the recurrent tumor group.